Attenuation of allergy to ovomucoid in pigs by neonatal treatment with heat-killed Escherichia coli or E. coli producing porcine IFN-gamma

Vet Immunol Immunopathol. 2009 Nov 15;132(1):78-83. doi: 10.1016/j.vetimm.2009.09.019. Epub 2009 Sep 24.

Abstract

Food allergy is epidemic and prompts investigation to reduce allergic predisposition. It was hypothesized that heat-killed Escherichia coli injected intramuscularly (im) with or without interferon gamma (IFN-gamma), reduces neonatal susceptibility to experimental egg allergy. Two litters of Yorkshire pigs were assigned to three intramuscular treatment groups (four/group): control (PBS), heat-killed E. coli with or without IFN-gamma-expressing plasmid. Pigs were sensitized to ovomucoid (Ovm) by intraperitoneal injection with cholera toxin. To assess induction of allergy, pigs were fed egg white in yoghurt and assigned scores for allergic signs. Significantly fewer pigs developed allergy and passive cutaneous anaphylaxis in E. coli and E. coli+IFN-gamma vs control groups. E. coli-treated pigs also had significantly lower frequency of mean clinical scores. E. coli and E. coli+IFN-gamma groups did not differ. Serum antibody associated with IgG (H & L), IgG(1), IgG(2) or IgE all correlated but did not differ by treatment groups. Thus, treatment of neonatal pigs with heat-killed E. coli by im injection reduced susceptibility to allergic sensitization with Ovm. Inclusion of the type-1 cytokine, IFN-gamma, had no additional effect. Results indicate a method for prophylaxis of allergy and suggest support for the "hygiene hypothesis".

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Escherichia coli / cytology
  • Escherichia coli / metabolism*
  • Hot Temperature
  • Humans
  • Hypersensitivity / immunology*
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / immunology*
  • Microbial Viability
  • Ovomucin / immunology*
  • Passive Cutaneous Anaphylaxis
  • Recombinant Proteins
  • Swine

Substances

  • Recombinant Proteins
  • Ovomucin
  • Interferon-gamma